Semax
Semax from Primeva Labs is offered strictly for research use only. Each order includes batch-specific CoA documentation, quality verification, and secure online ordering. Not for human or animal consumption.
Primeva Labs supplies materials strictly for laboratory and research use. Create a complimentary research account to view current pricing, availability, and ordering.
By creating an account you confirm you are 21+, agree to the Terms & Research-Use Disclaimer, and acknowledge these products are sold strictly for research use — not for human or animal consumption.
What Is Semax?
Semax is a synthetic peptide derived from a fragment of ACTH(4-10), developed in Russia and studied for neurotrophic (BDNF) and neuroprotective effects.
- Synthetic ACTH(4-10) analog with a C-terminal Pro-Gly-Pro extension
- Studied for BDNF upregulation and neuroplasticity
- A focus of nootropic and neuroprotection research
- Supplied strictly as a research-grade reference material
Research Applications
Neurotrophic research
Studied for upregulation of BDNF and nerve-growth-factor signaling.
Neuroprotection models
Examined for reduced infarct size in cerebral-ischemia research.
Cognition / learning studies
Investigated for effects on memory consolidation and attention in models.
Monoamine-signaling research
Explored for modulation of dopaminergic and serotonergic systems.
Proposed Mechanisms
BDNF / TrkB pathway
Increases BDNF expression and downstream TrkB signaling in brain regions.
Neuroprotective signaling
Associated with anti-apoptotic and anti-inflammatory effects in ischemia models.
Monoaminergic modulation
Studied for effects on dopamine and serotonin turnover.
Metabolic stability
The Pro-Gly-Pro extension improves resistance to enzymatic breakdown.
Mechanisms described above are drawn from preclinical (cell and animal) research and, where noted, early clinical literature. They are provided for educational context and should not be read as clinical or therapeutic claims.






